BioMarin Pharmaceutical Inc. said that the Board of Directors has appointed Ian T. Clark as Chair of the Board, subject to his election at the company's Annual Meeting of Stockholders on June 2, 2026. Mr. Clark will succeed Richard A. Meier, who is retiring after two decades on the Board, and the appointment will beco…
MCS Health announced the expansion of its senior leadership team as part of its continued investment in scaling a data-driven healthcare communications model built to identify new opportunities and transform client service. The agency has appointed Jamie Yacco as Executive Vice President, Elle Fitamant and Tiffany R…
The Medical College of Wisconsin (MCW) announced that Shekar N. Kurpad, MD, PhD, FEL '01, has been unanimously appointed as the institution's seventh president and chief executive officer (CEO), effective July 1, 2026. Dr. Kurpad currently serves as professor of Neurosurgery and senior associate dean, Neuroscience in …
symplr®, a leader in enterprise healthcare operations software backed by Clearlake Capital Group, L.P.and Charlesbank Capital Partners announced the appointment of Venkat Kavarthapu as Chief Executive Officer, effective immediately. He succeeds Chris Colpitts, who has served as interim CEO since November 2025. Mr. Col…
Boston Aesthetics announced the appointment of Brandon Nye as Chief Executive Officer, effective immediately. Nye will lead the company's strategic growth initiatives, commercial expansion, and operating execution as Boston Aesthetics enters its next phase of market development in the global medical aesthetics sector.…
Modular Devices announces the appointment of Steve Richter as Chief Executive Officer, responsible for overseeing enterprise-wide strategy, integration, performance, and alignment across the organization. As part of the new leadership structure, Mark Koers has transitioned into the role of President, Imaging and Heal…
Qlaris Bio, Inc., a clinical-stage biotechnology company developing first-in-class therapies for glaucoma, announced the appointment of Fred Guerard, Pharm.D., as president and chief executive officer (CEO), effective March 1, 2026. He will also join the company’s Board of Directors. “I am honored to join Qlaris at t…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Executive Vice President and Chief Financial Officer (CFO), R. Brent Jones, will leave the Company on or before June 24, 2026. Avantor has initi…
FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment of Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026. Bardroff will lead commercial and sales, business insights and …
Biocon Limited, announced the appointment of Shreehas Tambe as its Chief Executive Officer and Managing Director, effective April 1, 2026, following approvals from the Nomination & Remuneration Committee and the Board. As the first CEO of Biocon Limited he will lead the combined platform spanning biosimilars and g…
Page 5 of 15